New study tests if All-Keyhole surgery beats hybrid approach for esophageal cancer
NCT ID NCT07408999
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 3 trial will compare two surgical techniques for esophageal cancer: totally minimally invasive esophagectomy (TMIE) using only keyhole incisions, versus a hybrid approach that combines keyhole and open chest surgery. The study aims to see if TMIE reduces severe complications after surgery. About 327 adults with resectable esophageal or gastroesophageal junction cancer will take part across multiple centers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Totally Minimally Invasive Esophagectomy (TMIE) - a surgical procedure using thoracoscopy instead of open chest surgery
- What this could lead to
- If TMIE proves better, it could become the new standard surgical approach for esophageal cancer, leading to fewer severe complications and faster recovery.
- What could go wrong
- This is a surgical technique comparison, not a new drug or cure. The trial is not yet recruiting, and results may show no significant difference between the two approaches.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Lille
Lille, 59037, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Can a new infusion drug shrink Hard-to-Treat tumors?
- A high-tech camera may take the guesswork out of spotting a dangerous surgery complication
- Blood test score may flag High-Risk esophageal surgery patients
- Can a new drug combo shrink Hard-to-Treat tumors?
- Can surgery for stomach or esophageal cancer cloud the mind?